HealthTrust’s SurgIntel platform was recently awarded Modern Healthcare’s 2024 Best in Business Award for the Data Analytics category.
- SurgIntel is a clinical service line performance improvement and decision support platform designed to help hospitals, ASCs and health systems maximize margins, optimize procedural service lines, and drive meaningful provider engagement. Leveraging a proprietary database of over 3 million clinical and financial attributes, SurgIntel provides powerful insights into physician-level utilization, device benchmarking, and procedural cost variation across orthopedic, spine, and cardiovascular specialties. The platform enables stakeholders to identify unwarranted variation, align implant selection with clinical and financial outcomes, and make evidence-based decisions that support both quality care and operational efficiency.
- What sets SurgIntel apart is its unique ability to integrate complex procedural, and supply data into a dynamic visualization and decision support environment. By illuminating opportunities across both acute and non-acute care settings, the platform serves as a game changer in helping organizations implement data-driven strategies for margin maximization, service line optimization, and provider alignment. Its robust analytics engine supports contracting strategies, rebate tracking, and physician attribution models, empowering health systems to engage clinicians with meaningful, case-specific data that drives behavior change and supports value-based care transformation.
HealthTrust’s Commitment to Healthcare Innovation in 2024
HealthTrust is dedicated to fostering the responsible integration of cutting-edge technologies to advance our members’ patient care missions. Our core objective as a GPO in collaborating with innovators and members is to strategically align innovative products, platforms, and technologies with member needs, thereby enhancing care delivery while supporting innovation in healthcare.
Our innovation review process is meant to safeguard members from the proliferation of unproven “innovative technologies,” discerning true innovation from product enhancements. We provide a trusted, clinically led, multidisciplinary analysis, working
Addendum to HealthTrust’s 2025 HGPII Public Accountability Questionnaire
alongside our membership to distill over 1,000 innovation submissions to the top 100 meaningful products for potential impact each year, with 130 products reviewed in 2024.
Our unique position stems from exclusive supplier relationships, a commitment to clinically driven innovative solutions, and an influential member network of the top healthcare systems. This allows us to serve as an operational bridge, translating from innovative technology theories to bedside practicality.
Our HealthTrust Innovation Center is a web-based, open resource available to all innovative suppliers, independent of any contract cycle, offering four distinct avenues for true innovative partnerships year-round:
- Thought Leadership
- Commercialization Support
- Cost Effectiveness Collaboration
- Clinical Integration Strategy
HealthTrust’s Innovation Center connects health systems with the right resources through thought leadership, scientific research, and clinician expertise to determine cost effectiveness and clinical value of innovative products entering the market. These resources explore concerns and questions from our membership, providing valuable insights for sourcing and enhancing partnerships with suppliers in a responsible way.
***